drugset / Trial / NCT02993718
Sedation by Dexmedetomidine and Propofol
RandomizedParallel-groupSingle-blindSupportive care
Summary
Under the hypothesis that dexmedetomidine sedation would result in less upper airway obstruction, we evaluated the occurrence of upper airway collapse or the requirement of airway intervention in patients with obstructive sleep apnea during dexmedetomidine or propofol sedation.
Timeline
- Start
- 2015-01
- Primary completion
- 2017-06
- Completion
- 2017-06
Outcome
Met primary endpoint
paper there was a significantly lower proportion of patients exhibiting signs of upper airway obstruction in the dexmedetomidine group than in the propofol group (11.5% vs. 41.7%, P = 0.035). PMID 30185146 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 0.2 ug/kg | — |
| Subject | Dexmedetomidine | Other / unclassified | 0.8 ug/kg | — |
| Subject | Propofol | Small molecule | 0.5 ug/ml | — |
| Subject | Propofol | Small molecule | 2 ug/ml | — |
Indications
No indication recorded.